Figure 1
Design overview. (A) Schematic diagram of the study design. (B) Kaplan–Meier curves for OS of 780 HCC patients demonstrate that TP53-mutant patients have statistically significantly worse prognosis than TP53 wild-type patients (log-rank test, P < 0.00001).

Design overview. (A) Schematic diagram of the study design. (B) Kaplan–Meier curves for OS of 780 HCC patients demonstrate that TP53-mutant patients have statistically significantly worse prognosis than TP53 wild-type patients (log-rank test, P < 0.00001).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close